Overview


According to FutureWise analysis the market for Non-Invasive Blood Glucose Monitoring Devices is expected to reach US$ 0.35 billion by 2031 at a CAGR of 8.90%.

Diabetes is a common disease that affects about 8.5 percent of the world's population. It is critical to monitor the evolution of diabetes by checking blood glucose levels (BGLs) on a regular basis. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient's glucose level on a continuous basis. Non-invasive blood glucose monitoring devices use fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets to monitor their blood glucose levels at home. Noninvasive glucose monitoring reduces the need for unpleasant pricking, which increases the risk of infection and the amount of damage to the finger tissue. Non-invasive glucose monitoring has significant potential for improving diabetes management by allowing for more accurate and painless blood glucose testing, resulting in the growth of the Non-Invasive Blood Glucose Monitoring Devices Market over the forecast period. Without puncturing the skin or causing pain or harm, these gadgets calculate blood glucose levels in diabetic patients. The glucose monitoring equipment must follow the regular changes in blood glucose levels in diabetes individuals. The market is predicted to grow due to a rise in demand for smart diabetes control devices with technologically enhanced features. The Global Non-Invasive Blood Glucose Monitoring Devices Market is also predicted to grow due to the introduction of new products. The primary cause of diabetes is a change in food choices and lifestyle.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Non- Invasive Blood Glucose Monitoring Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Non- Invasive Blood Glucose Monitoring Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Animas Technologies
  • Bayer Healthcare
  • Cercacor
  • Pendragon Medical
  • OrSense

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  • MIR/NIR (Mid/Near Infrared Spectroscopy)
  • Raman Spectroscopy
  • Occlusion Spectroscopy
  • Optical Coherence Tomography
  • Thermal Emission Spectroscopy
  • Photoacoustic Spectroscopy
  • Impedance/Dielectric Spectroscopy
  • Electromagnetic
  • Polarimetry
  • Fluorescence

By Modality

  • Wearable Blood Glucose Monitoring Systems
  • Non-wearable /Table top Blood Glucose Monitoring Systems

By End User

  • Hospitals
  • Home Care Settings
  • Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Non- Invasive Blood Glucose Monitoring Devices Market By Technology, By Modality, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Non- Invasive Blood Glucose Monitoring Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Non- Invasive Blood Glucose Monitoring Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Non- Invasive Blood Glucose Monitoring Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Non- Invasive Blood Glucose Monitoring Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. MIR/NIR (Mid/Near Infrared Spectroscopy)
        2. Raman Spectroscopy
        3. Occlusion Spectroscopy
        4. Optical Coherence Tomography
        5. Thermal Emission Spectroscopy
        6. Photoacoustic Spectroscopy
        7. Impedance/Dielectric Spectroscopy
        8. Electromagnetic
        9. Polarimetry
        10. Fluorescence

  • 8.   Non- Invasive Blood Glucose Monitoring Devices Market, By Modality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Wearable Blood Glucose Monitoring Systems
        2. Non-wearable /Table top Blood Glucose Monitoring Systems

  • 9.   Non- Invasive Blood Glucose Monitoring Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Home Care Settings
        3. Clinics

  • 10.   North America Non- Invasive Blood Glucose Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Non- Invasive Blood Glucose Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Non- Invasive Blood Glucose Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Non- Invasive Blood Glucose Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Non- Invasive Blood Glucose Monitoring Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Animas Technologies
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bayer Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cercacor
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Pendragon Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. OrSense
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients